ARVO 2025

Imagine Eyes will exhibit at ARVO 2025 in Salt Lake City on May 05-08, 2025. We warmly welcome all attendees to visit us on our booth and discover a new range of possibilities for investigating retinal disease at the cellular level, and for advancing the development of retinal therapies.

Cellular and microvascular retinal assessments for clinical research and clinical trials

The rtx1 AO retinal camera reveals subclinical and clinical alterations at the microscopic scale, through quick exams. It provides quantification of cone cells, RPE cells and microvascular structure. Extensively validated by 250+ published studies, rtx1 enables investigating various retinal diseases, and tracking progression as well as therapy effects over shorter timescales than OCT or AF imaging.

As always, the rtx1 device comes to ARVO: We will be happy to introduce its current capabilities with live demos.

For trial sponsors and CROs

We offer global services for a successful implementation of AO biomarkers in studies and trials, thanks to our partner Emsere. Meet us at the event to discuss how to accelerate your developments of retinal therapies.